Since its founding in 2018, Florida-based cannabis company Jushi Holdings Inc. JUSHF, has made it a point to focus on specific U.S. markets where they could exploit competitive advantages.
They moved a step closer to that this week with the announced acquisition of Pennsylvania Medical Solutions. Jushi is acquiring the subsidiary of Vireo Health International Inc. VREOF for $37 million, which includes a 90,000 square-foot facility that manufactures various cannabis products, including indoor-grown flower, extracts, and concentrates.
“Pennsylvania has always been a market we liked,” Jushi Co-Founder and President Erich Mauff told Benzinga. “A logical next step was always to vertically integrate [in the state]. The market in Pennsylvania is very undersupplied when it comes to flower and finished products.”
The Importance Of Pennsylvania
According to Mauff, the company has always had its eyes on Pennsylvania.
“We think it’s one of the best medical markets in the U.S. We like Illinois as well, but the difference was Illinois already had some of the largest home grown companies. We thought Pennsylvania was a similarly interesting market because it’s a large state, it has a medical program that made it likely the state would consider adult use, and we were able to build our footprint more aggressively.”
Pennsylvania’s medical cannabis industry generated $524 million in sales in 2019. Currently, there are roughly 80 operational Pennsylvania dispensaries and just under 300,000 medical marijuana patients registered in the program, according to the Pennsylvania Department of Health.
Mauff said Jushi currently operates seven medical marijuana dispensaries in the state with the right to operate another eight, the maximum allowed in the state. That increased the need for a more robust growing presence. The plan, he said, is to spend the next 6-12 months building out their cultivation in the state. He didn’t shut the door on any potential future M&A, but said it would have to be under the right circumstances.
“When it comes to expansion we’ve always been clear. We want to vertically integrate in Illinois and Pennsylvania,” said Mauff. “We’ve now done that in Pennsylvania. We feel very good about our position and don’t feel the need to do anything more other than operate in our current markets.”
Image: Jushi
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.